Murray J F
Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital Medical Center, University of California 94143, USA.
Annu Rev Med. 1996;47:117-26. doi: 10.1146/annurev.med.47.1.117.
Pulmonary disease is a major source of morbidity and mortality in HIV-infected persons. Pneumocystis carinii pneumonia has decreased substantially during the last eight years, but in the United States it remains the most common disorder that announces the onset of AIDS. In contrast, tuberculosis is by far the most important AIDS-associated indicator disease in developing countries. Community-acquired acute bacterial pneumonia is a common HIV-linked complication throughout the world; pneumonia occurs at all levels of immune suppression but increases in frequency as CD4 counts decrease. Fungal infections mainly afflict persons who live or have lived in the various endemic areas. AIDS-related Kaposi's sarcoma and lymphoma generally do not involve the lungs until the malignancies are advanced. The increasing use of successful chemoprophylaxis against many important HIV-associated infections is increasing the incidence of other end-stage complications such as cytomegalovirus and disseminated MAC disease.
肺部疾病是艾滋病毒感染者发病和死亡的主要原因。在过去八年中,卡氏肺孢子虫肺炎的发病率已大幅下降,但在美国,它仍然是宣告艾滋病发病的最常见病症。相比之下,结核病是发展中国家迄今为止最重要的艾滋病相关指示性疾病。社区获得性急性细菌性肺炎是全球常见的与艾滋病毒相关的并发症;肺炎在各个免疫抑制水平都可能发生,但随着CD4细胞计数的下降,其发病率会增加。真菌感染主要影响生活在或曾生活在各种地方病流行地区的人群。与艾滋病相关的卡波西肉瘤和淋巴瘤通常在恶性肿瘤进展到晚期才会累及肺部。针对许多重要的与艾滋病毒相关感染的成功化学预防措施的使用日益增加,这也导致了其他终末期并发症的发生率上升,如巨细胞病毒和播散性鸟分枝杆菌复合体疾病。